Background Non-communicable diseases (NCDs) have slowly risen to the top of the global health agenda and the reduction of premature NCD mortality was recently enshrined in Target 3.4 of the UN Sustainable Development Goals. The unequal global distribution of NCDs is inadequately captured by the most commonly cited statistics.
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Previous WHO targets have focused exclusively on these 'big four' conditions. 2 The Global Burden of Disease project is the other major provider of comprehensive mortality data. Methodological differences lead to slightly different estimations in a number of areas; however, the level of variance compared to WHO data is negligible for most practical purposes.
In promoting a focus on the prevention and management of NCD, advocates commonly rely on a tried and tested triad of statistics to convey the global significance of NCDs and the disproportionate burden borne by developing countries: these conditions kill 38 million people each year; 28 million of these deaths occur in low-and middle-income countries (LMICs) and 82% of all premature deaths occur in LMICs (Fig. 2) . This triptych constitutes the first three of six 'key facts' headlining the WHO factsheet on NCDs, 1 and counters the enduring misconception that NCDs are 'diseases of affluence'. 3 The fact that 82% of all premature NCD deaths occur in LMICs is often used to argue that developing countries experience a disproportionate NCD burden, and to support arguments that the global distribution is unjust or unfair. The statistic can be found in the opening paragraph of Luke Allen, Researcher Linda Cobiac, Researcher Nick Townsend, Senior Researcher many NCD documents, speeches, policy briefings and NGO reports, framing NCDs as a development/social justice issue. A rich literature explores the use of simple figures-perceived as morally neutral and apolitical-to agitate for social change 4, 5 and Adams has drawn attention to the use of metrics in framing global health policy debates. 6 While the '82%' statistic succinctly conveys that the vast majority of premature mortality occurs in LMICs, it does not account for the fact that the vast majority of the world's population also lives in these countries. In fact, a simple analysis of the 2012 Global Health Estimate data shows that 82% of the world's population live in LMICs (Fig. 3) .
The absolute number of premature NCD deaths appears to be directly proportional to population size, which would lead some to question whether it is appropriate to claim that the larger absolute burden borne by LMICs is disproportionate or inequitable.
The aim of this study was to unpack the origins of the 82% statistic and quantify the relative risk of premature NCD mortality in each World Bank region. We intended to derive region-specific age-standardized death rates (ASDRs) and comparative measures of individual risk using established calculations and WHO demographic data.
The origins of the 82%
The '82%' statistic was first used in the 2013-20 NCD Global Action Plan to establish the epidemiological significance of NCDs. 7 It featured in the opening paragraphs of the forewords to this document, the 2014 NCD Country Profiles, and is a central theme in the 2014 Global Status Report. It is also frequently cited by the WHO Director General and her Deputy. 2, 7, 8 The statistic is drawn from the 2012 WHO Global Health Estimates (available online at http://www.who.int/healthinfo/statistics/ en/), based on the latest available national and WHO data. The WHO Department of Health Statistics and Information Systems is responsible for compiling these estimates and stratifies deaths by age, sex, country, WHO region and World Bank income group. The figure is important in highlighting the distribution of the absolute burden on NCDs, demonstrating that efforts to decrease the number of global NCD deaths must be focused on developing countries, as this is where the majority of these deaths occur.
The reasoning for focusing on premature deaths is intuitive but controversial (it has been denounced as ageist by a number QUANTIFYING THE GLOBAL DISTRIBUTION OF PREMATURE MORTALITY of charities). In essence, the vast majority of NCDs occurring before old age are preventable whereas arterial calcification, telomere shortening, etc. make cancer and cardiovascular disease an inevitable fact of later life. In a theoretically perfect health system, 100% of deaths would be from NCDs in old age so it makes sense to focus on premature (i.e. avoidable) mortality. In the 2011, UN High-Level Declaration on NCDs 'premature' deaths were defined as those occurring between the ages of 30 and 69 years. 9 Some subsequent documents have extended the lower bound downwards to birth 2 and it is likely that the Sustainable Development Goals will use 0-69 years. With this definition, 16 million NCD deaths were premature in 2012 according to Global Health Estimate data (42.1% of all NCD deaths).
The 82% statistic does not control for the global distribution of those under 70 years of age and therefore does not constitute an individual risk of premature NCD death, which is a more meaningful statistic when we want to compare those living in countries of different income levels. It is common practice to use mortality rates to account for differences in population size.
Crude rates account for population size but do not adjust for differences in the population distribution, i.e. countries that have a larger proportion of older individuals would expect to suffer a greater burden from diseases that occur at older ages, including NCDs. The use of a standard population allows death rates to be calculated as if all countries had the same population age distribution.
The WHO has developed a standard population to be used for calculating age-standardized rates. This is based on the average age structure of those populations to be compared (the world) over the likely period of time that a new standard will be used (some 25-30 years), using the 1998 UN assessment. 10 Age-standardized rates of premature mortality may be a more appropriate measure of the excess burden of premature mortality borne by LMICs as they control for demographic differences. They provide a risk relative to the standard population used, so can only be compared to rates standardized with the same standard population, and they may not be suitable when comparing countries with very different population profiles.
The WHO Global Monitoring Framework recommends using 'probability of dying between the ages of 30 and 70 years from [the big four] diseases' as a progress indicator for countries trying to attain a 25% reduction in overall mortality by 2025. 2 Applied to the World Bank groupings, this statistical approach could be used as a simple and transparent way of illustrating the outsized burden of premature NCD mortality borne by LMICs.
Methods
To calculate the probability of premature NCD mortality by World Bank region, we obtained population and mortality statistics from the WHO Global Health Estimates data set. NCD deaths were categorized as those from the four main disease subtypes: cardiovascular diseases, all cancers, diabetes and respiratory NCDs-as grouped in the Global Health Estimates. We totaled number of deaths and population size for World Bank-defined 'low', 'lower-middle', 'upper-middle' and 'high' income countries, 11 based on gross national income and using the Atlas method to reduce the impact of exchange rate fluctuations. 8 The
Crude rates (calculated using number of deaths and population size) were converted into ASDRs using the WHO 2000-25 standard population and the direct method. We calculated the risk of a 30-year old dying from cardiovascular disease, respiratory disease, diabetes mellitus or cancer NCD before their 70th birthday in the four World Bank regions using the age groupings from the 2012 Global Health Estimates, based on methods annexed in the Global Status Report (see Box 1). 2 We combined the data for low income, lower-middle income and upper-middle income to give an overall value for LMICs.
Results
The absolute number of premature NCD deaths is greatest in middle-income countries (over 4 million), with <1 million premature deaths in low-income countries. Crude death rates, adjusting for population size, are highest in lowermiddle income countries (4.5/1000, 95% CI: 4.2-4.8).
Upper middle-income countries (3.7/1000, 3.5-3.9) and low-income countries (3.5/1000, 3.3-3.7) have slightly higher crude death rates than HICs (3.4/1000, 3.2-3.6), with death rates for all developing countries 1.17 times higher than HICs at 4.0 per 1000 (3.8-4.2).
ASDRs using the WHO 2000-25 standard population are also highest in lower middle-income countries at 5.0 per 1000 population (95% CI: 4.8-5.3), low-income countries have the second highest ASDRs (4.2/1000, 4.0-4.5) and HICs have the lowest ASDRs (2.9/1000, 2.7-3.1).
Using the Global Status Report method, a 30-year old living in an lower middle-income country also has the greatest chance of dying from an NCD before the age of 70 (25.1%) and those living in HICs have the lowest risk (14.6%). Individuals living in developing countries have a 21.9% chance of dying from an NCD before reaching 70; a risk of premature death 1.5 times higher than those living in developed countries (see Table 1 and Fig. 4 ).
Discussion
Main findings of this study
The probability of a 30-year old dying from an NCD before reaching 70 years old is 21.9% in developing countries-1.5 times greater than the risk facing individuals in HICs. The absolute burden of premature NCD deaths is greatest in upper middle-income countries, however, after adjusting for population size and age distribution, rates are highest in lower-middle income countries. The probability of an individual dying before the age of 70 is also greatest in these settings. We find that developing countries bear a greater burden of NCD mortality than HICs irrespective of the metric used.
What is already known on this topic
The Global Status Report provides overall NCD mortality rates based on 2012 data, but not premature mortality rates. The figures for overall mortality demonstrate a similar patterns to those presented here with a larger burden in developing countries: overall NCD mortality rates in LMICs were Lower income countries have higher relative rates of premature death from all three classes of disease (NCDs, injuries, and communicable, maternal, perinatal and nutritional). This paper cannot explain why premature NCD death rates are highest in developing countries, but poverty, weak governance, rapid unplanned urbanization and unregulated economic activity may all play a role.
What this study adds
The probability of an individual dying before the age of 70, as calculated here, provides an intuitive way of comparing individual risk and therefore for allowing comparisons between developed and developing countries to be made. This study is also suggests that lower-middle income countries bear a greater relative burden of premature mortality than upper-middle income countries.
Our '1.5 times higher risk' figure is a more appropriate way of quantifying the unequal global distribution of premature mortality from NCDs than referring to the higher absolute number of deaths in LMICs.
There is a growing recognition that evidence should feed into global health policy making. 13 While recognizing that this process is 'messy and non-linear', 14 our finding that lowermiddle income countries bear the highest relative burden should inform future global NCD strategy. Our findings have particular relevance for second iteration of WHO 'best buys' that disproportionately draw on evidence from high-and upper-middle income countries. In quantifying the unequal global distribution of premature NCD mortality, this paper can be used to leverage more resources to develop, implement and evaluate effective NCD policies in LMICs.
Limitations of this study
The main strength of this study is the use of a number of methods to describe the relative burden and risk from NCD premature mortality, including the first comparison of risk of premature death for individuals living in developed and developing countries. The main weakness is that although we compare between countries in number of deaths, rates and probability of dying, we only adjust for age and do not consider other inequalities. For example, although countries are grouped into income classification, we do not examine inequalities within these countries. It may be that differences between developed and developing countries in the outcomes we present are due to greater inequalities by sex, socioeconomic status or ethnic inequities among others, within these countries. Urbanization and the growth of megacities are other important processes that may influence risk in transition economies. 15 Although the WHO data can be seen to be the highest quality mortality and population data comparable for all countries from one source, the WHO is reliant on the quality of national data provided by individual countries in most instances. The data are imperfect and 19% of countries did not have systems for recording cause-specific mortality in 2013. 16 
Conclusion
NCDs have a history of being marginalized and misrepresented. The 'risk of premature NCD mortality' controls for population size and age group, providing an intuitive way of comparing individual risk across World Bank regions.
We show that the risk of premature mortality is 1.5 times higher in LMICs than HICs. Though smaller than the 1:4 ratio implied by the ubiquitous '82%' statistic, the difference is still striking. We believe that this 1.5 relative risk is more appropriate because it describes the relative risk for individuals living in these countries, rather than the absolute burden of disease. Our figure can be used to illustrate the disproportionate burden of NCDs borne by developing countries.
